LillyDirect Foundayo Review
GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: the cheapest legal brand-name GLP-1
LillyDirect Foundayo scores highest on state availability and ease of access.
Orforglipron
Price checked on LillyDirect Foundayo’s site,
What the monthly price covers
Medication
Not stated
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to LillyDirect Foundayo
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
LillyDirect Foundayo at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $149/mo (Regular self-pay price, 1-month (30-day) supply.)
- Pricing model
- Scales with dose: higher doses cost more
- Availability
- All 50 states
- FDA status
- 3 FDA warning letters on record; see below
How we scored LillyDirect Foundayo
Each dimension is scored algorithmically from LillyDirect Foundayo’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.8/10LillyDirect Foundayo's brand-name medication starts at $149/mo. Its value score is measured against the $179 median for GLP-1 providers, which compounded programs set, so brand-name sellers score lower on value by design. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.5/10LillyDirect Foundayo offers orforglipron, an oral GLP-1 with promising late-stage trial data. It prescribes FDA-approved brand-name medication rather than compounded versions.
User Experience15%
7.8/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
6.7/10Key details fully confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
9.2/10LillyDirect Foundayo treats patients in all 50 states plus DC.
Support10%
6.8/10LillyDirect Foundayo provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this LillyDirect Foundayo review
Last checked August 2026- Confirmed current pricing across 6 dose/plan tiers
- Confirmed availability in all 50 states plus DC
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $25–$349/mo across 6 dose/plan tiers (checked August 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with LillyDirect Foundayo
We walked LillyDirect Foundayo’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Talk to your own doctor to see if Foundayo (orforglipron) is right for you.
- 2Ask your doctor to send the prescription to LillyDirect Pharmacy.
- 3A pharmacy partner reaches out to confirm details, explore savings, and choose pharmacy options.
- 4Free home delivery or pickup at a retail pharmacy.
- Self-pay prices shown publicly: from $149/mo (0.8mg) up to $349/mo (14.5mg & 17.2mg; $299 with the LillyDirect self-pay program if refilled within 45 days).
- As low as $25/month for eligible commercially-insured patients; a Medicare Part D 'GLP-1 Bridge' program is referenced.
- This is a manufacturer direct-to-patient pharmacy, not a telehealth prescriber: it requires an existing prescription from your own doctor, and there is no intake questionnaire on Lilly's side.
- Lilly can help you 'find a doctor' via Healthgrades, but the clinical consult is third-party.
- Fulfillment via third-party pharmacy partners with 24/7 pharmacist support.
GLP-1 medications LillyDirect Foundayo offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.
Regular self-pay price, 1-month (30-day) supply.
Regular self-pay price, 1-month supply.
Regular self-pay price, 1-month supply.
Regular self-pay price $349; available for $299 via an automatic purchase offer only if you complete your refill within 45 days of the delivery/receipt date of your previous Foundayo fill (14.5/17.2 mg only).
For eligible Medicare Part D patients. A bridge program, not a standing retail price.
Ready to get started?
Plans and promotions change often, so check LillyDirect Foundayo's current pricing and active discounts before you decide.
What we like
- Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
- Direct from the manufacturer, with no compounding and no third-party reseller
- Daily oral pill, no injections, no refrigeration
- Available in all 50 states
Watch-outs
- Lower mean weight loss than Wegovy (14.9%) and Zepbound (20.9%): labeled-dose 11.1% per Foundayo PI
- Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- $25 savings card requires commercial insurance; Medicare and Medicaid are not eligible
- Strict empty-stomach 30-minute window may be hard for some patients to follow
LillyDirect Foundayo: the drugmaker selling its own pill to you
Most providers on this site are telehealth companies or pharmacies that source a GLP-1 and resell it to you. LillyDirect Foundayo is something different: it is Eli Lilly, the manufacturer itself, selling its brand-name weight-loss pill straight to patients with no middleman, no compounding, and no reseller margin. Foundayo is the consumer brand for orforglipron, the first oral (pill-form) GLP-1 cleared for weight loss. If you have a valid prescription and you want the FDA-cleared branded product at the lowest price anyone is legally allowed to charge, this is the channel that sets the floor. The limit is that LillyDirect is a fulfillment pipe rather than a clinic: it will not see you, prescribe for you, or hold your hand.
How the pricing works (two completely different prices)
There are two Foundayo prices, and which one applies to you depends entirely on your insurance. If you are covered by commercial (employer or marketplace) insurance, the Lilly Savings Card brings your cost down to roughly twenty-five dollars a month, the cheapest legal path to any brand-name GLP-1 in 2026. That number comes from the manufacturer subsidizing its own list price to win the oral-GLP-1 market. Medicare and Medicaid patients are explicitly not eligible for that card, which knocks out a large share of the people who most want a cheaper option.
If you are paying cash, the price climbs with your dose. The entry dose starts at $149 a month, and the regular self-pay price steps up from there as you titrate to higher strengths, topping out in the mid-three-hundreds for the strongest doses. For reference, the category median is about $179, so the low doses undercut the field while the top doses sit near the middle. Lilly also runs an automatic refill offer that shaves the highest two doses down a notch, but only if you reorder within a tight 45-day window of your last delivery, so it rewards staying on schedule and penalizes gaps.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
- Commercially insured: about twenty-five dollars a month with the Lilly Savings Card
- Cash-pay, low dose: starts at $149/month
- Cash-pay, high dose: scales up into the mid-three-hundreds, with a conditional refill discount on the top strengths
- Medicare / Medicaid: not eligible for the savings card, so you pay cash rates
A daily pill, not an injection
Orforglipron is a once-daily oral GLP-1, with no needles, no auto-injectors, no refrigeration, and no compounding pharmacy in the chain. For people who have avoided GLP-1s purely because of the injection, that removes the single biggest barrier. It ships from LillyDirect's own pharmacy in all 50 states, so geography is not a problem the way it is with some compounders.
But the pill comes with a rule you have to respect: it must be taken on an empty stomach, with no more than a sip of water, and you wait about 30 minutes before eating, drinking, or taking other oral medications. Miss that window routinely and you blunt the drug. For a disciplined morning-routine person that is trivial; for someone with a chaotic schedule or other morning pills, it adds daily friction.
What it won't do: write your prescription
LillyDirect Foundayo is a pharmacy and pay channel. It does not include a medical visit, and it will not generate the prescription for you. You need a valid US prescription from a separate licensed prescriber (your own doctor, or an independent telehealth provider) before this channel can fill anything. So budget for that: a separate consult or visit fee somewhere else is part of the true cost of getting started here, even though the drug price looks low in isolation. Amazon One Medical solves that by pairing its clinicians with Amazon Pharmacy, which sells Foundayo.
How much weight loss to expect
Cheapest and easiest does not mean strongest. By the numbers in its own prescribing information, Foundayo's labeled-dose mean weight loss lands around 11%, which is clinically meaningful but below injectable semaglutide (Wegovy, in the neighborhood of 15%) and well below tirzepatide (Zepbound, around 21%). If your goal is the maximum possible weight loss and you can tolerate a weekly shot, an injectable will likely take you further. Foundayo's pitch is convenience, brand-name legitimacy, and price rather than peak efficacy.
Who should choose it, and who should skip it
- Choose it if: you have commercial insurance and want a brand-name GLP-1 for about twenty-five dollars a month, you strongly prefer a pill over injections, or you specifically distrust compounded products and want the manufacturer's exact product.
- Skip it if: you are on Medicare or Medicaid (no savings card), you want an all-in-one service that prescribes and ships together, you can't reliably hold the empty-stomach window, or you are chasing the largest possible weight loss and would do better on an injectable.
Trust and oversight
On product quality this is as straightforward as it gets. The drug is brand-name and FDA-approved, dispensed by the manufacturer's own pharmacy, with no compounding and no third-party sourcing. Eli Lilly does have active FDA warning letters: in September 2025 the agency cited three promotional videos for Zepbound and Mounjaro that left out risk information, and two of them mention LillyDirect. Those letters concern advertising, not the drug you receive. What you are NOT buying is clinical care: there is no built-in medical team monitoring your dose or side effects, because that responsibility stays with whoever wrote your prescription. So the oversight is excellent on product quality and intentionally absent on patient management. See our scoring methodology for how we weigh that split.
Bottom line
LillyDirect Foundayo is the price floor and the legitimacy benchmark for oral GLP-1s in 2026. If you are commercially insured and already have a prescriber, almost nothing beats it on cost-per-real-brand-drug, and the daily-pill format makes daily life easier for people who dislike injections. The trade-offs are equally clear: you bring your own prescription and your own clinical follow-up, the savings card excludes government insurance, the empty-stomach rule demands discipline, and the weight loss trails the strongest injectables. Buy it as a clean, cheap, manufacturer-direct supply of a brand-name pill, not for the full-service experience it doesn't pretend to offer.
The Bottom Line
LillyDirect Foundayo scores highest on state availability and ease of access.
Ready to start with LillyDirect Foundayo?
From $149/mo. See current pricing and start your free consultation.
LillyDirect Foundayo might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare LillyDirect Foundayo vs…
LillyDirect Foundayo scores8.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
LillyDirect Foundayo vs Amazon One Medical
Amazon One Medical scores 8.5/10

LillyDirect Foundayo vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Eli Lilly and Company, which runs LillyDirect, received an FDA warning letter dated September 9, 2025
The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this LillyDirect Foundayo review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See LillyDirect Foundayo's current pricing
Plans from $149/mo. Start your free consultation to check eligibility and today's price.